6. Provigil - Top 10 Warnings and Recalls

Drug: Provigil

2006 sales: $727 million

Manufacturer: Cephalon

Safety concern: Warning; Stevens-Johnson syndrome, psychiatric problems

Related Articles:
> FDA warns of Provigil risks. Report
> Cephalon shares tank after Sparlon (Provigil) rejection. Report
> FDA staffers question safety of Provigil for ADHD. Report

6. Provigil - Top 10 Warnings and Recalls
Read more on

Suggested Articles

Sanofi will unload six manufacturing sites and 3,100 employees into a new API production company as it looks for €2 billion in cost savings.

With a new target date approaching for its competitor to Lantus, the FDA has again given Biocon’s insulin manufacturing plant in Malaysia a once over.

Despite outcomes data that left analysts less-than-enthused, Eli Lilly's Trulicity scored the FDA's nod to lower CV risks in a first-ever approval.